Immunovant (IMVT) Total Debt (2018 - 2023)

Immunovant (IMVT) has 4 years of Total Debt data on file, last reported at $350000.0 in Q1 2023.

• Quarterly Total Debt rose 104.68% year-over-year to $350000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $350000.0 (up 104.68% YoY) and the FY2023 annual result came in at $350000.0, up 104.68% from the prior year.
• Total Debt advanced to $350000.0 in Q1 2023, from $171000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $5.0 million in Q2 2019 to a low of $58000.0 in Q1 2019.
• A 4-year average of $1.7 million and a median of $350000.0 in 2023 frame the typical range for Total Debt.
• The widest YoY moves for Total Debt: up 5400.0% in 2020, down 94.64% in 2020.
• Tracing IMVT's Total Debt over 4 years: stood at $3.1 million in 2019, then sank by 95.72% to $134000.0 in 2020, then increased by 27.61% to $171000.0 in 2022, then surged by 104.68% to $350000.0 in 2023.
• The last three Total Debt figures came in at $350000.0 (Q1 2023), $171000.0 (Q1 2022), and $134000.0 (Q3 2020), per Business Quant data.